Year: 2022

logo-124

China Bispecific Antibody Market Opportunity & Clinical Trials Report 2022-2028: Comprehensive Insights On More Than 80 Bispecific Antibodies Available For Licensing/Partnership – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. At...